Key Details
Price
$2.15Annual EPS
-$5.46Annual ROE
31.93%Beta
3.81Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
N/ARecent annual earnings:
N/ANext ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Nov 29, 2024Analyst ratings
Recent major analysts updates
01 Nov '24 Maxim Group
BuyScreeners with SLXN included
No data
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Biomotion Sciences Ordinary Shares doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
Silexion Therapeutics Announces 1-for-9 Reverse Share Split
SLXN
globenewswire.com22 November 2024
Trading on split-adjusted basis will begin at market open on November 29, 2024. This adjustment is expected to help Silexion comply with NASDAQ requirements, enhance its market position, and support its strategic growth initiatives Trading on split-adjusted basis will begin at market open on November 29, 2024. This adjustment is expected to help Silexion comply with NASDAQ requirements, enhance its market position, and support its strategic growth initiatives
FAQ
- What is the primary business of Biomotion Sciences Ordinary Shares?
- What is the ticker symbol for Biomotion Sciences Ordinary Shares?
- Does Biomotion Sciences Ordinary Shares pay dividends?
- What sector is Biomotion Sciences Ordinary Shares in?
- What industry is Biomotion Sciences Ordinary Shares in?
- What country is Biomotion Sciences Ordinary Shares based in?
- When did Biomotion Sciences Ordinary Shares go public?
- Is Biomotion Sciences Ordinary Shares in the S&P 500?
- Is Biomotion Sciences Ordinary Shares in the NASDAQ 100?
- Is Biomotion Sciences Ordinary Shares in the Dow Jones?
- When does Biomotion Sciences Ordinary Shares report earnings?
- Should I buy Biomotion Sciences Ordinary Shares stock now?
What is the primary business of Biomotion Sciences Ordinary Shares?
Biomotion Sciences focuses on developing innovative solutions in the field of biotechnology, aiming to improve health outcomes through advanced scientific research and technology.
What is the ticker symbol for Biomotion Sciences Ordinary Shares?
The ticker symbol for Biomotion Sciences Ordinary Shares is NASDAQ:SLXN
Does Biomotion Sciences Ordinary Shares pay dividends?
No, Biomotion Sciences Ordinary Shares does not pay dividends
What sector is Biomotion Sciences Ordinary Shares in?
Biomotion Sciences Ordinary Shares is in the Healthcare sector
What industry is Biomotion Sciences Ordinary Shares in?
Biomotion Sciences Ordinary Shares is in the Biotechnology industry
What country is Biomotion Sciences Ordinary Shares based in?
Biomotion Sciences Ordinary Shares is headquartered in Israel
When did Biomotion Sciences Ordinary Shares go public?
Biomotion Sciences Ordinary Shares's initial public offering (IPO) was on 07 April 2021
Is Biomotion Sciences Ordinary Shares in the S&P 500?
No, Biomotion Sciences Ordinary Shares is not included in the S&P 500 index
Is Biomotion Sciences Ordinary Shares in the NASDAQ 100?
No, Biomotion Sciences Ordinary Shares is not included in the NASDAQ 100 index
Is Biomotion Sciences Ordinary Shares in the Dow Jones?
No, Biomotion Sciences Ordinary Shares is not included in the Dow Jones index
When does Biomotion Sciences Ordinary Shares report earnings?
The date for Biomotion Sciences Ordinary Shares's next earnings report has not been announced yet
Should I buy Biomotion Sciences Ordinary Shares stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions